Free Trial
NASDAQ:PTPI

Petros Pharmaceuticals (PTPI) Stock Price, News & Analysis

Petros Pharmaceuticals logo
$0.03 +0.00 (+3.68%)
As of 07/25/2025 03:59 PM Eastern

About Petros Pharmaceuticals Stock (NASDAQ:PTPI)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.13
52-Week Range
$0.02
$16.25
Volume
361,189 shs
Average Volume
5.64 million shs
Market Capitalization
$965.96 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PTPI Stock News Headlines

The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
Petros Pharmaceuticals, Inc. (PTPI) - Yahoo Finance
See More Headlines

PTPI Stock Analysis - Frequently Asked Questions

Petros Pharmaceuticals' stock was trading at $9.8475 at the beginning of the year. Since then, PTPI stock has decreased by 99.7% and is now trading at $0.0310.

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) posted its quarterly earnings data on Thursday, May, 15th. The company reported ($8.46) EPS for the quarter.

Petros Pharmaceuticals's stock reverse split on Thursday, May 1st 2025.The 1-25 reverse split was announced on Tuesday, April 29th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of PTPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Petros Pharmaceuticals investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), Bank of America (BAC), Abbott Laboratories (ABT), Cricut (CRCT) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
5/15/2025
Today
7/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PTPI
CIK
1815903
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($60.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.16 million
Net Margins
N/A
Pretax Margin
-117.50%
Return on Equity
-78.22%
Return on Assets
-23.50%

Debt

Debt-to-Equity Ratio
1.58
Current Ratio
0.85
Quick Ratio
0.74

Sales & Book Value

Annual Sales
$5.11 million
Price / Sales
0.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.04 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
31,160,000
Free Float
9,932,000
Market Cap
$965.96 thousand
Optionable
Not Optionable
Beta
1.56
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:PTPI) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners